| HIV导致免疫系统B细胞耗尽 作者: 来源:科讯网 发布者: 亦云 类别:新闻扫描 日期: 2008-07-18 今日/总浏览: 94/94 |
|||
|
HIV immune system B-cell depletion
-------------------------------------------------- ------------------------------
Author: Source: Bureau's network publishers: Yiyun categories: News Scan date: 2008-07-18 Today / Total View: 94/94
Recent studies have shown that, HIV can cause immune system to produce strong and lasting immune response, leading to the key immune system cells - CD4 + and CD8 + T cell depletion, CD4 + and CD8 + T cells to resist HIV is the body's main immune cells . Exhausted immune cells to resist HIV's ability to lower and lower, eventually the failure of immune cells lose the ability to deal with HIV, the removal of the loss in the ability of HIV.
Now the U.S. National Allergy and Infectious Diseases Research Center, studies have shown that a similar failure of the immune system is also another kind of cell in there, that is secreted protein B cell antibodies.
Most did not receive anti-retroviral therapy to AIDS patients in the continuous replication of HIV, leading to more body tissues and organs dysfunction, Paul trigger blood circulation in the sub-type B cells change. One of the sub-category is organizations like memory B cells, B cells in the absence of such anti-retroviral therapy of HIV infection especially rich in content. B cells showed such precocious and low anti-HIV decline in the ability, the ability of antibody production decline.
HIV infected persons in addition to CD4 + and CD8 + T cells failure, the new findings show that, B cells failure, and this is proved that HIV can damage the body's immune system complicated, we treat the challenge is to re-establish or support HIV infection The immune system.
U.S. National allergy and infectious diseases research center of the vaccine research project's goal is to enhance understanding of B-cell research, promoting vaccine research and development, this research is to make a contribution to the goal. The researchers hope to design a therapeutic vaccine, slow HIV disease process, so that failure of B-cell secretion restore the ability of high-quality antibodies.
Author:
Source: Bureau's network
Publisher: Yiyun
-------------------------------------------------- ------------------------------
Author: Source: Bureau's network publishers: Yiyun categories: News Scan date: 2008-07-18 Today / Total View: 94/94
Recent studies have shown that, HIV can cause immune system to produce strong and lasting immune response, leading to the key immune system cells - CD4 + and CD8 + T cell depletion, CD4 + and CD8 + T cells to resist HIV is the body's main immune cells . Exhausted immune cells to resist HIV's ability to lower and lower, eventually the failure of immune cells lose the ability to deal with HIV, the removal of the loss in the ability of HIV.
Now the U.S. National Allergy and Infectious Diseases Research Center, studies have shown that a similar failure of the immune system is also another kind of cell in there, that is secreted protein B cell antibodies.
Most did not receive anti-retroviral therapy to AIDS patients in the continuous replication of HIV, leading to more body tissues and organs dysfunction, Paul trigger blood circulation in the sub-type B cells change. One of the sub-category is organizations like memory B cells, B cells in the absence of such anti-retroviral therapy of HIV infection especially rich in content. B cells showed such precocious and low anti-HIV decline in the ability, the ability of antibody production decline.
HIV infected persons in addition to CD4 + and CD8 + T cells failure, the new findings show that, B cells failure, and this is proved that HIV can damage the body's immune system complicated, we treat the challenge is to re-establish or support HIV infection The immune system.
U.S. National allergy and infectious diseases research center of the vaccine research project's goal is to enhance understanding of B-cell research, promoting vaccine research and development, this research is to make a contribution to the goal. The researchers hope to design a therapeutic vaccine, slow HIV disease process, so that failure of B-cell secretion restore the ability of high-quality antibodies.
Author:
Source: Bureau's network
Publisher: Yiyun